Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Lipid and brain volumetric measures in multiple sclerosis patients: findings from a large observational study

B. Lorincz, M. Vrablik, R. Murali, EK. Havrdova, D. Horakova, J. Krasensky, M. Vaneckova, T. Uher

. 2024 ; 124 (6) : 1981-1988. [pub] 20241025

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003195

Grantová podpora
64165 RVO VFN

OBJECTIVES: This study aimed to investigate relationships between cholesterol profile, brain volumetric MRI, and clinical measures in a large observational cohort of multiple sclerosis (MS) patients. MATERIALS AND METHODS: We included 1.505 patients with 4.966 time points including complete lipid, clinical, and imaging data. The time among lipid, brain MRI and clinical measures was under 90 days. Cross-sectional statistical analysis at baseline was performed using an adjusted linear regression and analysis of longitudinal lipid and MRI measures data was performed using adjusted linear mixed models. RESULTS: We found associations between higher high-density lipoprotein cholesterol (HDL-C) and lower brain parenchymal fraction (BPF) at cross-sectional analysis at baseline (B = -0.43, CI 95%: -0.73, -0.12, p = 0.005), as well as in longitudinal analysis over follow-up (B = -0.32 ± 0.072, χ2 = 36.6; p = < 0.001). Higher HDL-C was also associated with higher T2-lesion volume in longitudinal analysis (B = 0.11 ± 0.023; χ2 = 23.04; p = < 0.001). We observed a weak negative association between low-density lipoprotein cholesterol (LDL-C) levels and BPF at baseline (B = -0.26, CI 95%: -0.4, -0.11, p = < 0.001) as well as in longitudinal analysis (B = -0.06 ± 0.03, χ2 = 4.46; p = 0.03). T2-LV did not show an association with LDL-C. We did not find any association between lipid measures and disability. The effect of lipid levels on MRI measures and disability was minimal (Cohen f2 < 0.02). CONCLUSIONS: Our results contradict the previously described exclusively positive effect of HDL-C on brain atrophy in patients with MS. Higher LDL-C was weakly associated with higher brain atrophy but not with higher lesion burden.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003195
003      
CZ-PrNML
005      
20250206104110.0
007      
ta
008      
250121s2024 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13760-024-02676-w $2 doi
035    __
$a (PubMed)39455532
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Lorincz, Balazs $u Department of Neurology, Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
245    10
$a Lipid and brain volumetric measures in multiple sclerosis patients: findings from a large observational study / $c B. Lorincz, M. Vrablik, R. Murali, EK. Havrdova, D. Horakova, J. Krasensky, M. Vaneckova, T. Uher
520    9_
$a OBJECTIVES: This study aimed to investigate relationships between cholesterol profile, brain volumetric MRI, and clinical measures in a large observational cohort of multiple sclerosis (MS) patients. MATERIALS AND METHODS: We included 1.505 patients with 4.966 time points including complete lipid, clinical, and imaging data. The time among lipid, brain MRI and clinical measures was under 90 days. Cross-sectional statistical analysis at baseline was performed using an adjusted linear regression and analysis of longitudinal lipid and MRI measures data was performed using adjusted linear mixed models. RESULTS: We found associations between higher high-density lipoprotein cholesterol (HDL-C) and lower brain parenchymal fraction (BPF) at cross-sectional analysis at baseline (B = -0.43, CI 95%: -0.73, -0.12, p = 0.005), as well as in longitudinal analysis over follow-up (B = -0.32 ± 0.072, χ2 = 36.6; p = < 0.001). Higher HDL-C was also associated with higher T2-lesion volume in longitudinal analysis (B = 0.11 ± 0.023; χ2 = 23.04; p = < 0.001). We observed a weak negative association between low-density lipoprotein cholesterol (LDL-C) levels and BPF at baseline (B = -0.26, CI 95%: -0.4, -0.11, p = < 0.001) as well as in longitudinal analysis (B = -0.06 ± 0.03, χ2 = 4.46; p = 0.03). T2-LV did not show an association with LDL-C. We did not find any association between lipid measures and disability. The effect of lipid levels on MRI measures and disability was minimal (Cohen f2 < 0.02). CONCLUSIONS: Our results contradict the previously described exclusively positive effect of HDL-C on brain atrophy in patients with MS. Higher LDL-C was weakly associated with higher brain atrophy but not with higher lesion burden.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a roztroušená skleróza $x diagnostické zobrazování $x krev $x patologie $7 D009103
650    12
$a magnetická rezonanční tomografie $7 D008279
650    12
$a mozek $x diagnostické zobrazování $x patologie $7 D001921
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a průřezové studie $7 D003430
650    12
$a HDL-cholesterol $x krev $7 D008076
650    _2
$a longitudinální studie $7 D008137
650    _2
$a LDL-cholesterol $x krev $7 D008078
650    _2
$a kohortové studie $7 D015331
650    _2
$a cholesterol $x krev $7 D002784
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Vrablik, Michal $u Third Department of Internal Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
700    1_
$a Murali, Ramanathan $u Department of Pharmaceutical Sciences and Neurology, University at Buffalo, State University of New York, Buffalo, NY, USA
700    1_
$a Havrdova, Eva Kubala $u Department of Neurology, Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
700    1_
$a Horakova, Dana $u Department of Neurology, Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
700    1_
$a Krasensky, Jan $u Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
700    1_
$a Vaneckova, Manuela $u Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
700    1_
$a Uher, Tomas $u Department of Neurology, Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic. tomas.uher@vfn.cz $1 https://orcid.org/0000000331609022 $7 xx0189534
773    0_
$w MED00000090 $t Acta neurologica Belgica $x 2240-2993 $g Roč. 124, č. 6 (2024), s. 1981-1988
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39455532 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104106 $b ABA008
999    __
$a ok $b bmc $g 2263128 $s 1239202
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 124 $c 6 $d 1981-1988 $e 20241025 $i 2240-2993 $m Acta neurologica Belgica $n Acta Neurol Belg $x MED00000090
GRA    __
$a 64165 $p RVO VFN
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...